Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |